Pyrazolo-pyridinone derivatives and methods of use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S253040, C514S303000, C544S127000, C544S362000, C546S119000

Reexamination Certificate

active

08080546

ABSTRACT:
The present invention comprises a new class of compounds useful for the prophylaxis and treatment of pro-inflammatory cytokine mediated diseases, and in particular, p38 activity mediated inflammation and related conditions. The compounds have a general Formula Iwherein A1, A2, A3, A4, A5, R1, R2and R3are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of inflammatory diseases including rheumatoid arthritis, psoriasis and other disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.

REFERENCES:
patent: 2004056823 (2004-07-01), None
patent: 2004076450 (2004-09-01), None
patent: 2004099156 (2004-11-01), None
patent: 2005063766 (2005-07-01), None
patent: 2007062805 (2007-06-01), None
Org.Biomol.Chem.2005,3(12),2262-70.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazolo-pyridinone derivatives and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazolo-pyridinone derivatives and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo-pyridinone derivatives and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4306144

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.